<DOC>
	<DOCNO>NCT01082731</DOCNO>
	<brief_summary>Data burden MIP low transmission area , Latin America , limit ; even less information efficacy case management MiP . The treatment recommendation MiP Latin American country change rapidly recent month ; currently , either artemether-lumefantrine ( AL ) mefloquine-artesunate ( MA ) first line treatment P. falciparum ( depend country ) ; however , data exists efficacy drug treatment malaria pregnancy Latin America support use . We propose multi-center 2-arm open-label randomized Phase 4 clinical trial ass safety efficacy present therapy , AL MA . We hypothesize drug efficacious use pregnant woman Brazil .</brief_summary>
	<brief_title>Efficacy Artemisinin Combination Therapies Treatment Uncomplicated P. Falciparum Pregnancy Brazil</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<criteria>1 . Gestational age &gt; 16 week ( determine LMP fundal height ) discordance two , conservative estimate ( i.e . low ) use , prevent accidental exposure 1st trimester fetus 2 . Normal fetal heart beat detect Doppler 3 . Presence P. falciparum parasitemia â‰¤ 50,000 parasites/microliter ( thick film ) 4 . Willing sign thumb print inform consent 5 . Willing return schedule follow visit treatment observation delivery 6 . Willing deliver health facility 1 . Pregnancy &lt; 16 week 2 . Microscopically confirm P. vivax mixed infection/ parasitemia ( P. falciparum another specie Plasmodium , i.e . P. vivax , P. ovale , P. malariae ) 3 . History allergy hypersensitivity interventional drug 4 . Exposure antimalarial drug drug antimalarial activity within past 2 month , determine history woman ( quinine , mefloquine , artemisinin derivative , include AL MA ) 5 . Patients take drug possible interaction study drug ( ie . warfarin , digoxin ) 6 . History family history epilepsy psychiatric disorder 7 . Presence sign symptom severe malaria 8 . Hemoglobin &lt; 7 g/dl 9 . Inability tolerate oral medication ( repeat vomiting , impairment consciousness ) . 10 . History chronic disease include diabetes , renal failure , hepatic failure , heart disease require antiarrhythmic drug warfarin , HIV AIDS , know hemoglobinopathy 11 . Participant 's inability return follow visit 12 . Age &lt; 15 year</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>Treatment</keyword>
	<keyword>Brazil</keyword>
</DOC>